Hyperalgesia in Opioid-Managed Chronic Pain and Opioid-Dependent Patients

Journal of Pain

Volumn 10, Issue 3, 2009, Pages 316-322

  Hay, Justin L ^a   White, Jason M ^a,b   Bochner, Felix ^a,c   Somogyi, Andrew A ^a,c   Semple, Tim J ^c   Rounsefell, Bruce ^c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b Drug & Alcohol Services South Australia   (Australia)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

antinociception; chronic pain; methadone; morphine; Pain

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; CELECOXIB; CODEINE PHOSPHATE; DIAZEPAM; DICLOFENAC POTASSIUM; GABAPENTIN; KETOPROFEN; MELOXICAM; METHADONE; MORPHINE; NITRAZEPAM; OPIATE DERIVATIVE; PARACETAMOL; ROFECOXIB; TEMAZEPAM; TRAMADOL; VALPROIC ACID;

ADULT; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; COLD PRESSOR TEST; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; ELECTROSTIMULATION; FEMALE; HUMAN; HYPERALGESIA; MALE; NOCICEPTION; OBSERVATIONAL STUDY; PAIN ASSESSMENT; PAIN THRESHOLD; STATISTICAL ANALYSIS; TECHNIQUE; VON FREY HAIR;

ADULT; ANALGESICS, OPIOID; CHRONIC DISEASE; DRUG TOLERANCE; FEMALE; HUMANS; HYPERALGESIA; MALE; METHADONE; MIDDLE AGED; MORPHINE; OPIOID-RELATED DISORDERS; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD;

EID: 60849124199     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2008.10.003     Document Type: Article

References (47)

1. Ali N.M. Hyperalgesic response in a patient receiving high concentrations of spinal morphine. Anesthesiology 65 (1986) 449
2. Angst M.S., and Clark J.D. Opioid-induced hyperalgesia: A qualitative systematic review. Anesthesiology 104 (2006) 570-587
3. Aronson M.D. Nonsteroidal anti-inflammatory drugs, traditional opioids, and tramadol: Contrasting therapies for the treatment of chronic pain. Clin Ther 19 (1997) 420-432
4. Aubrun F., Langeron O., Quesnel C., Coriat P., and Riou B. Relationships between measurement of pain using visual analog score and morphine requirements during postoperative intravenous morphine titration. Anesthesiology 98 (2003) 1415-1421
5. Ayonrinde O.T., and Bridge D.T. The rediscovery of methadone for cancer pain management. Med J Aust 173 (2000) 536-540
6. Beaver W.T., Wallenstein S.L., Houde R.W., and Rogers A. A clinical comparison of the analgesic effects of methadone and morphine administered intramuscularly, and of orally and parenterally administered methadone. Clin Pharmacol Ther 8 (1967) 415-426
7. Burstein R., Cutrer M.F., and Yarnitsky D. The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain 123 Pt 8 (2000) 1703-1709
8. Chen A.C., Dworkin S.F., Haug J., and Gehrig J. Human pain responsivity in a tonic pain model: Psychological determinants. Pain 37 (1989) 143-160
9. Chu L.F., Clark D.J., and Angst M.S. Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: A preliminary prospective study. J Pain 7 (2006) 43-48
10. Cohen M.J., Naliboff B.D., Schandler S.L., and Heinrich R.L. Signal detection and threshold measures to loud tones and radiant heat in chronic low back pain patients and cohort controls. Pain 16 (1983) 245-252
11. Compton M.A. Cold-pressor pain tolerance in opiate and cocaine abusers: Correlates of drug type and use status. J Pain Symptom Manage 9 (1994) 462-473
12. Compton P., Charuvastra V.C., and Ling W. Pain intolerance in opioid-maintained former opiate addicts: Effect of long-acting maintenance agent. Drug Alcohol Depend 63 (2001) 139-146
13. De Conno F., Caraceni A., Martini C., Spoldi E., Salvetti M., and Ventafridda V. Hyperalgesia and myoclonus with intrathecal infusion of high-dose morphine. Pain 47 (1991) 337-339
14. Dole V.P., and Nyswander M. A medical treatment for diacetylmorphine (heroin) addiction. JAMA 193 (1965) 80-84
15. Doverty M., White J.M., Somogyi A.A., Bochner F., Ali R., and Ling W. Hyperalgesic responses in methadone maintenance patients. Pain 90 (2001) 91-96
16. Eccleston C., and Crombez G. Pain demands attention: A cognitive-affective model of the interruptive function of pain. Psychol Bull 125 (1999) 356-366
17. Fillingim R.B., Doleys D.M., Edwards R.R., and Lowery D. Clinical characteristics of chronic back pain as a function of gender and oral opioid use. Spine 28 (2003) 143-150
18. Fishbain D.A., Rosomoff H.L., and Rosomoff R.S. Drug abuse, dependence, and addiction in chronic pain patients. Clin J Pain 8 (1992) 77-85
19. Handelsman L., Cochrane K.J., Aronson M.J., Ness R., Rubinstein K.J., and Kanof P.D. Two new rating scales for opiate withdrawal. Am J Drug Alcohol Abuse 13 (1987) 293-308
20. Ho A., and Dole V.P. Pain perception in drug-free and in methadone-maintained human ex-addicts. Proc Soc Exp Biol Med 162 (1979) 392-395
21. Jensen T.S., Gottrup H., Sindrup S.H., and Bach F.W. The clinical picture of neuropathic pain. Eur J Pharmacol 429 (2001) 1-11
22. Li X., Angst M.S., and Clark J.D. Opioid-induced hyperalgesia and incisional pain. Anesth Analg 93 (2001) 204-209
23. Li X., Angst M.S., and Clark J.D. A murine model of opioid-induced hyperalgesia. Brain Res Mol Brain Res 86 (2001) 56-62
24. Li X., and Clark J.D. Hyperalgesia during opioid abstinence: Mediation by glutamate and substance p. Anesth Analg 95 (2002) 979-984
25. Ling W, Cunningham-Rathner J, Fradis J, Torrington M, Keating M, White J. Opioid-induced hyperalgesia: Effects of buprenorphine treatment. Presented at the Meeting of the College on Problems of Drug Dependence, Miami, FL. 2003
26. Mao J., Price D.D., and Mayer D.J. Thermal hyperalgesia in association with the development of morphine tolerance in rats: Roles of excitatory amino acid receptors and protein kinase C. J Neurosci 14 (1994) 2301-2312
27. Mao J., Sung B., Ji R.R., and Lim G. Chronic morphine induces downregulation of spinal glutamate transporters: Implications in morphine tolerance and abnormal pain sensitivity. J Neurosci 22 (2002) 8312-8323
28. Martin J.E., and Inglis J. Pain tolerance and narcotic addiction. Br J Soc Clin Psychol 4 (1965) 224-229
29. Martin W.R., Jasinski D.R., Haertzen C.A., Kay D.C., Jones B.E., Mansky P.A., and Carpenter R.W. Methadone: A reevaluation. Arch Gen Psychiatry 28 (1973) 286-295
30. Merskey H., and Bogduk N. Classification of Chronic Pain: IASP Task Force on Taxonomy (1994), IASP Press, Seattle, WA 209-214
31. Mitchell T.B., White J.M., Somogyi A.A., and Bochner F. Switching between methadone and morphine for maintenance treatment of opioid dependence: Impact on pain sensitivity and mood status. Am J Addict 15 (2006) 311-315
32. Oken M.M., Creech R.H., Tormey D.C., Horton J., Davis T.E., McFadden E.T., and Carbone P.P. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5 (1982) 649-655
33. Parkinson S.K., Bailey S.L., Little W.L., and Mueller J.B. Myoclonic seizure activity with chronic high-dose spinal opioid administration. Anesthesiology 72 (1990) 743-745
34. Potter J.M., Reid D.B., Shaw R.J., Hackett P., and Hickman P.E. Myoclonus associated with treatment with high doses of morphine: The role of supplemental drugs. BMJ 299 (1989) 150-153
35. Pud D., Cohen D., Lawental E., and Eisenberg E. Opioids and abnormal pain perception: New evidence from a study of chronic opioid addicts and healthy subjects. Drug Alcohol Depend 82 (2006) 218-223
36. Reznikov I., Pud D., and Eisenberg E. Oral opioid administration and hyperalgesia in patients with cancer or chronic nonmalignant pain. Br J Clin Pharmacol 60 (2005) 311-318
37. Schmidt A.J., and Brands A.M. Persistence behavior of chronic low back pain patients in an acute pain situation. J Psychosom Res 30 (1986) 339-346
38. Sjøgren P., Jonsson T., Jensen N.H., Drenck N.E., and Jensen T.S. Hyperalgesia and myoclonus in terminal cancer patients treated with continuous intravenous morphine. Pain 55 (1993) 93-97
39. Toombs J.D., and Kral L.A. Methadone treatment for pain states. Am Fam Physician 71 (2005) 1353-1358
40. van Damme S., Crombez G., Eccleston C., and Koster E.H. Hypervigilance to learned pain signals: A componential analysis. J Pain 7 (2006) 346-357
41. Vanderah T.W., Gardell L.R., Burgess S.E., Ibrahim M., Dogrul A., Zhong C.M., Zhang E.T., Malan Jr. T.P., Ossipov M.H., Lai J., and Porreca F. Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. J Neurosci 20 (2000) 7074-7079
42. Vanderah T.W., Suenaga N.M., Ossipov M.H., Malan Jr. T.P., Lai J., and Porreca F. Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance. J Neurosci 21 (2001) 279-286
43. Walsh N.E., Schoenfeld L., Ramamurthy S., and Hoffman J. Normative model for cold pressor test. Am J Phys Med Rehabil 68 (1989) 6-11
44. Wesson D., Ling W., and Jara G. Buprenorphine in pharmacotherapy of opioid addiction: Implementation in office-based medical practice. Translating the Experience of Clinical Trials into Clinical Practice (1999), California Society of Addiction Medicine, San Francisco, CA
45. Wesson D.R., and Ling W. The Clinical Opiate Withdrawal Scale (COWS). J Psychoactive Drugs 35 (2003) 253-259
46. White J.M. Pleasure into pain: The consequences of long-term opioid use. Addict Behav 29 (2004) 1311-1324
47. Woolf C.J. Intrathecal high dose morphine produces hyperalgesia in the rat. Brain Res 209 (1981) 491-495